SAKAR.NS Sakar Healthcare Limited

P/E 83.94565
Forward P/E 28.32396
Price/Sales 9.349434
Beta 0.441
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Sakar Healthcare is trading 6% up

Sakar Healthcare is trading 6.00% up at INR 1008.70 in the October 14, 2026 price context; available reporting has not established a direct catalyst. - It...

🔴 Sakar Healthcare is trading 5% down

Sakar Healthcare is trading at ₹931.10 (-5.13%), with no clear company-specific announcement identified to explain the decline. - The latest exchange update...

🔴 Sakar Healthcare is trading 5% down amid broad market weakness

Sakar Healthcare is trading 5.05% down at ₹951.80, amid broad Indian-market weakness; available reports identified no clear company-specific announcement...

🔴 Sakar Healthcare is trading 5% down

Sakar Healthcare is trading 5.23% down at ₹1,018.80; the supplied information does not establish a cause. - Searches found no fresh company announcement or...

🟢 Sakar Healthcare is trading 5% up today on broader healthcare-sector strength

Sakar Healthcare is trading 5% up at ₹1,185.00 after broader healthcare-sector strength. - The healthcare sector is up 1.27% amid renewed biotechnology...

🔴 Sakar Healthcare is trading 5.32% down today

Sakar Healthcare is trading at INR 1077.00, 5.32% down now after closing at INR 1137.55 on September 15, 2026, with no clear company-specific announcement...

🟢 Sakar Healthcare is trading 5% up today — no fresh company-specific announcement identified

Sakar Healthcare is trading 5.12% up at INR 1174.55 after a sharp multi-session rally. - Shares gained 14.20% on September 8 and 11.86% on September 1. - No...

🟢 Sakar Healthcare Limited is trading 16.04% up

SAKAR.NS is trading at $1176.55, up 16.04%.

Sakar Healthcare's 14 Oncology Approvals Spark a 10% Rally — But Can a Small Indian Drugmaker Really Break Into Europe's Cancer Market?

Sakar Healthcare's 14 Oncology Approvals Spark a 10% Rally — But Can a Small Indian Drugmaker Really Break Into Europe's Cancer Market?

Shares of Sakar Healthcare surged 10.5% to ₹1,120 on September 7 after the company announced it had secured 14 oncology product approvals across the EU, UK,...

🟢 Sakar Healthcare is trading 10.46% up today after 14 oncology approvals across three markets

Sakar Healthcare is trading 10.46% up now at ₹1120.00 after receiving 14 oncology-product approvals across the EU, UK and Canada. - The September 1...

🟢 Sakar Healthcare is trading 5.32% up today after 14 oncology approvals across EU, UK and Canada

Sakar Healthcare is trading at ₹1067.80, up +5.32%, following 14 oncology-product approvals across the EU, UK, and Canada announced September 1. - Approvals...

🟢 Sakar Healthcare is trading 10.30% up as no clear company-specific catalyst was identified

Sakar Healthcare is trading at INR 952.25, up 10.30%, with no clear company-specific catalyst identified for the August 31, 2026 session. - The latest filing,...

🟢 Sakar Healthcare is trading 6.33% up

Sakar Healthcare is trading at INR 918.00, up +6.33%, with no clear company-specific catalyst identified for the August 31, 2026 session. - The latest filing,...